chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 antibody test, X-ray limb
Clinical narrative: High fever for 18 days; chills; elevated WBC and RBC; elevated WBC and RBC; night sweats; cough; flank pain on right side; organ inflammation (elevated creatine protein); organ inflammation (elevated creatine protein); high liver numbers; severe headache; This is a spontaneous report from a contactable consumer. A 69-year-old male patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EN6203), dose 2 via an unspecified route of administration, administered in Arm Left on 12Mar2021 16:00 AM as DOSE 2, SINGLE for covid-19 immunisation (at the age of 69-year-old). Medical history included glaucoma and High blood pressure from an unknown date and unknown if ongoing. Not known allergies. Concomitant medications included atorvastatin (ATORVASTATIN), brimonidine tartrate, timolol maleate (COMBIGAN), hydro-chlorothiazide, valsartan (DIOVAN HCT), latanoprost (XALATAN) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (Lot number EL9264) in Arm Left on 12Feb2021 16:00 AM as dose 1, single for covid-19 immunisation. On 13Mar2021 06:00 patient experienced High fever for 18 days, chills, night sweats, cough, flank pain on right side, high liver numbers, elevated WBC and RBC, organ inflammation (elevated creatine protein); severe headaches. After 4 weeks symptoms are starting to lessen. The patient underwent lab tests and procedures which included blood creatine: elevated, blood test: unknown, computerised tomo-gram: unknown, electrocardiogram: unknown, liver function test: high, red blood cell count: elevated, ultrasound scan: unknown, urine analysis: unknown, white blood cell count: elevated on an unspecified date, sars-cov-2 test negative (Nasal Swab) on 22Mar2021. Adverse event resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The received treatment. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood creatine, Blood creatine increased, Blood test, Chills, Computerised tomogram
Clinical narrative: High fever for 18 days; chills; elevated WBC and RBC; elevated WBC and RBC; night sweats; cough; flank pain on right side; organ inflammation (elevated creatine protein); organ inflammation (elevated creatine protein); high liver numbers; severe headache; This is a spontaneous report from a contactable consumer. A 69-year-old male patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EN6203), dose 2 via an unspecified route of administration, administered in Arm Left on 12Mar2021 16:00 AM as DOSE 2, SINGLE for covid-19 immunisation (at the age of 69-year-old). Medical history included glaucoma and High blood pressure from an unknown date and unknown if ongoing. Not known allergies. Concomitant medications included atorvastatin (ATORVASTATIN), brimonidine tartrate, timolol maleate (COMBIGAN), hydro-chlorothiazide, valsartan (DIOVAN HCT), latanoprost (XALATAN) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (Lot number EL9264) in Arm Left on 12Feb2021 16:00 AM as dose 1, single for covid-19 immunisation. On 13Mar2021 06:00 patient experienced High fever for 18 days, chills, night sweats, cough, flank pain on right side, high liver numbers, elevated WBC and RBC, organ inflammation (elevated creatine protein); severe headaches. After 4 weeks symptoms are starting to lessen. The patient underwent lab tests and procedures which included blood creatine: elevated, blood test: unknown, computerised tomo-gram: unknown, electrocardiogram: unknown, liver function test: high, red blood cell count: elevated, ultrasound scan: unknown, urine analysis: unknown, white blood cell count: elevated on an unspecified date, sars-cov-2 test negative (Nasal Swab) on 22Mar2021. Adverse event resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The received treatment. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Electrocardiogram, Flank pain, Headache, Hepatic enzyme abnormal
Clinical narrative: High fever for 18 days; chills; elevated WBC and RBC; elevated WBC and RBC; night sweats; cough; flank pain on right side; organ inflammation (elevated creatine protein); organ inflammation (elevated creatine protein); high liver numbers; severe headache; This is a spontaneous report from a contactable consumer. A 69-year-old male patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EN6203), dose 2 via an unspecified route of administration, administered in Arm Left on 12Mar2021 16:00 AM as DOSE 2, SINGLE for covid-19 immunisation (at the age of 69-year-old). Medical history included glaucoma and High blood pressure from an unknown date and unknown if ongoing. Not known allergies. Concomitant medications included atorvastatin (ATORVASTATIN), brimonidine tartrate, timolol maleate (COMBIGAN), hydro-chlorothiazide, valsartan (DIOVAN HCT), latanoprost (XALATAN) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (Lot number EL9264) in Arm Left on 12Feb2021 16:00 AM as dose 1, single for covid-19 immunisation. On 13Mar2021 06:00 patient experienced High fever for 18 days, chills, night sweats, cough, flank pain on right side, high liver numbers, elevated WBC and RBC, organ inflammation (elevated creatine protein); severe headaches. After 4 weeks symptoms are starting to lessen. The patient underwent lab tests and procedures which included blood creatine: elevated, blood test: unknown, computerised tomo-gram: unknown, electrocardiogram: unknown, liver function test: high, red blood cell count: elevated, ultrasound scan: unknown, urine analysis: unknown, white blood cell count: elevated on an unspecified date, sars-cov-2 test negative (Nasal Swab) on 22Mar2021. Adverse event resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The received treatment. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Inflammation, Liver function test, Night sweats, Pyrexia, Red blood cell count
Clinical narrative: High fever for 18 days; chills; elevated WBC and RBC; elevated WBC and RBC; night sweats; cough; flank pain on right side; organ inflammation (elevated creatine protein); organ inflammation (elevated creatine protein); high liver numbers; severe headache; This is a spontaneous report from a contactable consumer. A 69-year-old male patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EN6203), dose 2 via an unspecified route of administration, administered in Arm Left on 12Mar2021 16:00 AM as DOSE 2, SINGLE for covid-19 immunisation (at the age of 69-year-old). Medical history included glaucoma and High blood pressure from an unknown date and unknown if ongoing. Not known allergies. Concomitant medications included atorvastatin (ATORVASTATIN), brimonidine tartrate, timolol maleate (COMBIGAN), hydro-chlorothiazide, valsartan (DIOVAN HCT), latanoprost (XALATAN) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (Lot number EL9264) in Arm Left on 12Feb2021 16:00 AM as dose 1, single for covid-19 immunisation. On 13Mar2021 06:00 patient experienced High fever for 18 days, chills, night sweats, cough, flank pain on right side, high liver numbers, elevated WBC and RBC, organ inflammation (elevated creatine protein); severe headaches. After 4 weeks symptoms are starting to lessen. The patient underwent lab tests and procedures which included blood creatine: elevated, blood test: unknown, computerised tomo-gram: unknown, electrocardiogram: unknown, liver function test: high, red blood cell count: elevated, ultrasound scan: unknown, urine analysis: unknown, white blood cell count: elevated on an unspecified date, sars-cov-2 test negative (Nasal Swab) on 22Mar2021. Adverse event resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The received treatment. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Red blood cell count increased, SARS-CoV-2 test, Ultrasound scan, Urine analysis, White blood cell count
Clinical narrative: High fever for 18 days; chills; elevated WBC and RBC; elevated WBC and RBC; night sweats; cough; flank pain on right side; organ inflammation (elevated creatine protein); organ inflammation (elevated creatine protein); high liver numbers; severe headache; This is a spontaneous report from a contactable consumer. A 69-year-old male patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EN6203), dose 2 via an unspecified route of administration, administered in Arm Left on 12Mar2021 16:00 AM as DOSE 2, SINGLE for covid-19 immunisation (at the age of 69-year-old). Medical history included glaucoma and High blood pressure from an unknown date and unknown if ongoing. Not known allergies. Concomitant medications included atorvastatin (ATORVASTATIN), brimonidine tartrate, timolol maleate (COMBIGAN), hydro-chlorothiazide, valsartan (DIOVAN HCT), latanoprost (XALATAN) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (Lot number EL9264) in Arm Left on 12Feb2021 16:00 AM as dose 1, single for covid-19 immunisation. On 13Mar2021 06:00 patient experienced High fever for 18 days, chills, night sweats, cough, flank pain on right side, high liver numbers, elevated WBC and RBC, organ inflammation (elevated creatine protein); severe headaches. After 4 weeks symptoms are starting to lessen. The patient underwent lab tests and procedures which included blood creatine: elevated, blood test: unknown, computerised tomo-gram: unknown, electrocardiogram: unknown, liver function test: high, red blood cell count: elevated, ultrasound scan: unknown, urine analysis: unknown, white blood cell count: elevated on an unspecified date, sars-cov-2 test negative (Nasal Swab) on 22Mar2021. Adverse event resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The received treatment. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: High fever for 18 days; chills; elevated WBC and RBC; elevated WBC and RBC; night sweats; cough; flank pain on right side; organ inflammation (elevated creatine protein); organ inflammation (elevated creatine protein); high liver numbers; severe headache; This is a spontaneous report from a contactable consumer. A 69-year-old male patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EN6203), dose 2 via an unspecified route of administration, administered in Arm Left on 12Mar2021 16:00 AM as DOSE 2, SINGLE for covid-19 immunisation (at the age of 69-year-old). Medical history included glaucoma and High blood pressure from an unknown date and unknown if ongoing. Not known allergies. Concomitant medications included atorvastatin (ATORVASTATIN), brimonidine tartrate, timolol maleate (COMBIGAN), hydro-chlorothiazide, valsartan (DIOVAN HCT), latanoprost (XALATAN) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (Lot number EL9264) in Arm Left on 12Feb2021 16:00 AM as dose 1, single for covid-19 immunisation. On 13Mar2021 06:00 patient experienced High fever for 18 days, chills, night sweats, cough, flank pain on right side, high liver numbers, elevated WBC and RBC, organ inflammation (elevated creatine protein); severe headaches. After 4 weeks symptoms are starting to lessen. The patient underwent lab tests and procedures which included blood creatine: elevated, blood test: unknown, computerised tomo-gram: unknown, electrocardiogram: unknown, liver function test: high, red blood cell count: elevated, ultrasound scan: unknown, urine analysis: unknown, white blood cell count: elevated on an unspecified date, sars-cov-2 test negative (Nasal Swab) on 22Mar2021. Adverse event resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The received treatment. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Blood test normal, Chest X-ray normal, Dehydration, Electrocardiogram
Clinical narrative: Constant burning in center of chest; Multiple episodes of racing heart (over 150bpm); feeling of extreme dread, fear, anxiety; feeling of extreme dread, fear, anxiety; Daily feeling of fatigue; lethargy; Cold sensations on arms and back; This is a spontaneous report from a contactable consumer or other non HCP (patient). A 37-year-old non pregnant female patient received bnt162b2 (BNT162B2 formulation; Solution for injection Lot Number: EP6955) via an unspecified route of administration, administered in Arm Left on 27Mar2021 at 12:00 as dose 1, single (at the age of 37-year-old) for COVID-19 immunisation. The patient medical history included none relevant history. Concomitant medications (Other medications in two weeks) included colecalciferol (D3), Birth control pill and Multivitamin, all taken for an unspecified indication, start and stop date were not reported. The patient was not pregnant at the time of vaccination. The patient did not have COVID prior vaccination. No known allergies. The patient not received other vaccine in four weeks. The patient not tested for COVID post vaccination. On 27Mar2021 at 12:00, the patient experienced multiple episodes of racing heart (over 150bpm), feeling of extreme dread fear, anxiety, daily feeling of fatigue, lethargy, cold sensations on arms and back and constant burning in centre of chest. The events caused Emergency room and physician office visit. It was reported that events still expediting after almost 3 weeks post vaccine. The patient underwent lab tests and procedure which included heart rate resulted as racing heart over 150 bpm on 27Mar2021. No treatment received for the events. The outcome of events reported as not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased, Paraesthesia, Throat tightness
Clinical narrative: Constant burning in center of chest; Multiple episodes of racing heart (over 150bpm); feeling of extreme dread, fear, anxiety; feeling of extreme dread, fear, anxiety; Daily feeling of fatigue; lethargy; Cold sensations on arms and back; This is a spontaneous report from a contactable consumer or other non HCP (patient). A 37-year-old non pregnant female patient received bnt162b2 (BNT162B2 formulation; Solution for injection Lot Number: EP6955) via an unspecified route of administration, administered in Arm Left on 27Mar2021 at 12:00 as dose 1, single (at the age of 37-year-old) for COVID-19 immunisation. The patient medical history included none relevant history. Concomitant medications (Other medications in two weeks) included colecalciferol (D3), Birth control pill and Multivitamin, all taken for an unspecified indication, start and stop date were not reported. The patient was not pregnant at the time of vaccination. The patient did not have COVID prior vaccination. No known allergies. The patient not received other vaccine in four weeks. The patient not tested for COVID post vaccination. On 27Mar2021 at 12:00, the patient experienced multiple episodes of racing heart (over 150bpm), feeling of extreme dread fear, anxiety, daily feeling of fatigue, lethargy, cold sensations on arms and back and constant burning in centre of chest. The events caused Emergency room and physician office visit. It was reported that events still expediting after almost 3 weeks post vaccine. The patient underwent lab tests and procedure which included heart rate resulted as racing heart over 150 bpm on 27Mar2021. No treatment received for the events. The outcome of events reported as not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Chest pain, Fatigue, Fear, Feeling cold
Clinical narrative: Constant burning in center of chest; Multiple episodes of racing heart (over 150bpm); feeling of extreme dread, fear, anxiety; feeling of extreme dread, fear, anxiety; Daily feeling of fatigue; lethargy; Cold sensations on arms and back; This is a spontaneous report from a contactable consumer or other non HCP (patient). A 37-year-old non pregnant female patient received bnt162b2 (BNT162B2 formulation; Solution for injection Lot Number: EP6955) via an unspecified route of administration, administered in Arm Left on 27Mar2021 at 12:00 as dose 1, single (at the age of 37-year-old) for COVID-19 immunisation. The patient medical history included none relevant history. Concomitant medications (Other medications in two weeks) included colecalciferol (D3), Birth control pill and Multivitamin, all taken for an unspecified indication, start and stop date were not reported. The patient was not pregnant at the time of vaccination. The patient did not have COVID prior vaccination. No known allergies. The patient not received other vaccine in four weeks. The patient not tested for COVID post vaccination. On 27Mar2021 at 12:00, the patient experienced multiple episodes of racing heart (over 150bpm), feeling of extreme dread fear, anxiety, daily feeling of fatigue, lethargy, cold sensations on arms and back and constant burning in centre of chest. The events caused Emergency room and physician office visit. It was reported that events still expediting after almost 3 weeks post vaccine. The patient underwent lab tests and procedure which included heart rate resulted as racing heart over 150 bpm on 27Mar2021. No treatment received for the events. The outcome of events reported as not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate, Lethargy, Palpitations
Clinical narrative: Constant burning in center of chest; Multiple episodes of racing heart (over 150bpm); feeling of extreme dread, fear, anxiety; feeling of extreme dread, fear, anxiety; Daily feeling of fatigue; lethargy; Cold sensations on arms and back; This is a spontaneous report from a contactable consumer or other non HCP (patient). A 37-year-old non pregnant female patient received bnt162b2 (BNT162B2 formulation; Solution for injection Lot Number: EP6955) via an unspecified route of administration, administered in Arm Left on 27Mar2021 at 12:00 as dose 1, single (at the age of 37-year-old) for COVID-19 immunisation. The patient medical history included none relevant history. Concomitant medications (Other medications in two weeks) included colecalciferol (D3), Birth control pill and Multivitamin, all taken for an unspecified indication, start and stop date were not reported. The patient was not pregnant at the time of vaccination. The patient did not have COVID prior vaccination. No known allergies. The patient not received other vaccine in four weeks. The patient not tested for COVID post vaccination. On 27Mar2021 at 12:00, the patient experienced multiple episodes of racing heart (over 150bpm), feeling of extreme dread fear, anxiety, daily feeling of fatigue, lethargy, cold sensations on arms and back and constant burning in centre of chest. The events caused Emergency room and physician office visit. It was reported that events still expediting after almost 3 weeks post vaccine. The patient underwent lab tests and procedure which included heart rate resulted as racing heart over 150 bpm on 27Mar2021. No treatment received for the events. The outcome of events reported as not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Chills, Dry skin, Erythema, Fatigue
Clinical narrative: Platelets almost doubled; Rash on upper left arm/rash spread to upper right arm and a few spots on knees; This is a spontaneous report from a contactable consumer or other non hcp. A 60-years-old female patient received first dose of bnt162b2 ((PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number was not reported, expiry date was not reported) via an unspecified route of administration on 10Mar2021 (at the age of 60-year-old)  as DOSE 1, SINGLE for covid-19 immunisation. Medical history included polycythaemia vera. Concomitant medications included losartan, hydroxycarbamide (HYDROXYUREA) and anagrelide (MANUFACTURER UNKNOWN). The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 06:00 the patient experienced rash on upper left arm, on 20Mar2021, rash spread to upper right arm and a few spots on knees and on 23Mar2021, platelets almost doubled. The patient underwent lab tests and procedures blood draw on 23Mar2021 and the result was platelets almost doubled since last count three weeks prior. Therapeutic measures were taken as a result of the event rash on upper left arm and upper right arm and a few spots on knees which included treatment with topical cream on an unknown date and therapeutic measures taken as a result of platelet almost doubled included increase anagrelide to two pills twice a day on 23Mar2021. The patient was diagnosed as having erythema multiforme (diagnosed by general practitioner) after second dose. The clinical outcome of the events was recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021387207 similar report from same reporter
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site rash, Pain in extremity, Paraesthesia, Peripheral swelling, Rash
Clinical narrative: Platelets almost doubled; Rash on upper left arm/rash spread to upper right arm and a few spots on knees; This is a spontaneous report from a contactable consumer or other non hcp. A 60-years-old female patient received first dose of bnt162b2 ((PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number was not reported, expiry date was not reported) via an unspecified route of administration on 10Mar2021 (at the age of 60-year-old)  as DOSE 1, SINGLE for covid-19 immunisation. Medical history included polycythaemia vera. Concomitant medications included losartan, hydroxycarbamide (HYDROXYUREA) and anagrelide (MANUFACTURER UNKNOWN). The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 06:00 the patient experienced rash on upper left arm, on 20Mar2021, rash spread to upper right arm and a few spots on knees and on 23Mar2021, platelets almost doubled. The patient underwent lab tests and procedures blood draw on 23Mar2021 and the result was platelets almost doubled since last count three weeks prior. Therapeutic measures were taken as a result of the event rash on upper left arm and upper right arm and a few spots on knees which included treatment with topical cream on an unknown date and therapeutic measures taken as a result of platelet almost doubled included increase anagrelide to two pills twice a day on 23Mar2021. The patient was diagnosed as having erythema multiforme (diagnosed by general practitioner) after second dose. The clinical outcome of the events was recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021387207 similar report from same reporter
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Skin warm, Somnolence
Clinical narrative: Platelets almost doubled; Rash on upper left arm/rash spread to upper right arm and a few spots on knees; This is a spontaneous report from a contactable consumer or other non hcp. A 60-years-old female patient received first dose of bnt162b2 ((PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number was not reported, expiry date was not reported) via an unspecified route of administration on 10Mar2021 (at the age of 60-year-old)  as DOSE 1, SINGLE for covid-19 immunisation. Medical history included polycythaemia vera. Concomitant medications included losartan, hydroxycarbamide (HYDROXYUREA) and anagrelide (MANUFACTURER UNKNOWN). The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 06:00 the patient experienced rash on upper left arm, on 20Mar2021, rash spread to upper right arm and a few spots on knees and on 23Mar2021, platelets almost doubled. The patient underwent lab tests and procedures blood draw on 23Mar2021 and the result was platelets almost doubled since last count three weeks prior. Therapeutic measures were taken as a result of the event rash on upper left arm and upper right arm and a few spots on knees which included treatment with topical cream on an unknown date and therapeutic measures taken as a result of platelet almost doubled included increase anagrelide to two pills twice a day on 23Mar2021. The patient was diagnosed as having erythema multiforme (diagnosed by general practitioner) after second dose. The clinical outcome of the events was recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021387207 similar report from same reporter
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Platelet count increased, Rash
Clinical narrative: Platelets almost doubled; Rash on upper left arm/rash spread to upper right arm and a few spots on knees; This is a spontaneous report from a contactable consumer or other non hcp. A 60-years-old female patient received first dose of bnt162b2 ((PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number was not reported, expiry date was not reported) via an unspecified route of administration on 10Mar2021 (at the age of 60-year-old)  as DOSE 1, SINGLE for covid-19 immunisation. Medical history included polycythaemia vera. Concomitant medications included losartan, hydroxycarbamide (HYDROXYUREA) and anagrelide (MANUFACTURER UNKNOWN). The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 06:00 the patient experienced rash on upper left arm, on 20Mar2021, rash spread to upper right arm and a few spots on knees and on 23Mar2021, platelets almost doubled. The patient underwent lab tests and procedures blood draw on 23Mar2021 and the result was platelets almost doubled since last count three weeks prior. Therapeutic measures were taken as a result of the event rash on upper left arm and upper right arm and a few spots on knees which included treatment with topical cream on an unknown date and therapeutic measures taken as a result of platelet almost doubled included increase anagrelide to two pills twice a day on 23Mar2021. The patient was diagnosed as having erythema multiforme (diagnosed by general practitioner) after second dose. The clinical outcome of the events was recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021387207 similar report from same reporter
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Gastrointestinal pain, Headache
Clinical narrative: Chills; fever; every inch of body aching; intestinal AGONY; rash; headache; nausea; incredible fatigue/fatigued; site of shot pain; Diarrhea; full blown flu/virus; This is a spontaneous report from a contactable consumer (patient). A 73-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: er8734) via an unspecified route of administration in left arm on 01Apr2021 at 14:30 (at the age of 73-year-old) as single dose for COVID-19 immunization. Medical history of the patient was not reported. Patient received other medications (unspecified) within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Patient previously took Compazine, Percocet, Morphine on an unspecified dates and experienced allergy. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: en6206) via an unspecified route of administration in left arm on an unspecified date in Mar2021 at 15:00 as single dose for COVID-19 immunization. On 01Apr2021 at 22:00 patient experienced chills, fever, every inch of body aching, intestinal agony, rash, headache, nausea, incredible fatigue, site of shot pain- full blown flu/virus, diarrhea. On day 8 patient was still so fatigued and cannot do anything. Diarrhea has stopped but headaches remained, and arm still aches. Patient haven't been this sick in years. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. Patient did not receive any treatment. Outcome of the event diarrhea was resolved on an unspecified date and for other events were not recovered.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Influenza, Injection site pain, Loss of personal independence in daily activities, Malaise, Nausea
Clinical narrative: Chills; fever; every inch of body aching; intestinal AGONY; rash; headache; nausea; incredible fatigue/fatigued; site of shot pain; Diarrhea; full blown flu/virus; This is a spontaneous report from a contactable consumer (patient). A 73-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: er8734) via an unspecified route of administration in left arm on 01Apr2021 at 14:30 (at the age of 73-year-old) as single dose for COVID-19 immunization. Medical history of the patient was not reported. Patient received other medications (unspecified) within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Patient previously took Compazine, Percocet, Morphine on an unspecified dates and experienced allergy. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: en6206) via an unspecified route of administration in left arm on an unspecified date in Mar2021 at 15:00 as single dose for COVID-19 immunization. On 01Apr2021 at 22:00 patient experienced chills, fever, every inch of body aching, intestinal agony, rash, headache, nausea, incredible fatigue, site of shot pain- full blown flu/virus, diarrhea. On day 8 patient was still so fatigued and cannot do anything. Diarrhea has stopped but headaches remained, and arm still aches. Patient haven't been this sick in years. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. Patient did not receive any treatment. Outcome of the event diarrhea was resolved on an unspecified date and for other events were not recovered.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pain in extremity, Pyrexia, Rash
Clinical narrative: Chills; fever; every inch of body aching; intestinal AGONY; rash; headache; nausea; incredible fatigue/fatigued; site of shot pain; Diarrhea; full blown flu/virus; This is a spontaneous report from a contactable consumer (patient). A 73-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: er8734) via an unspecified route of administration in left arm on 01Apr2021 at 14:30 (at the age of 73-year-old) as single dose for COVID-19 immunization. Medical history of the patient was not reported. Patient received other medications (unspecified) within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Patient previously took Compazine, Percocet, Morphine on an unspecified dates and experienced allergy. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: en6206) via an unspecified route of administration in left arm on an unspecified date in Mar2021 at 15:00 as single dose for COVID-19 immunization. On 01Apr2021 at 22:00 patient experienced chills, fever, every inch of body aching, intestinal agony, rash, headache, nausea, incredible fatigue, site of shot pain- full blown flu/virus, diarrhea. On day 8 patient was still so fatigued and cannot do anything. Diarrhea has stopped but headaches remained, and arm still aches. Patient haven't been this sick in years. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. Patient did not receive any treatment. Outcome of the event diarrhea was resolved on an unspecified date and for other events were not recovered.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Influenza, Nausea, Pain, Pyrexia, Rash
Clinical narrative: Chills; fever; every inch of body aching; intestinal AGONY; rash; headache; nausea; incredible fatigue/fatigued; site of shot pain; Diarrhea; full blown flu/virus; This is a spontaneous report from a contactable consumer (patient). A 73-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: er8734) via an unspecified route of administration in left arm on 01Apr2021 at 14:30 (at the age of 73-year-old) as single dose for COVID-19 immunization. Medical history of the patient was not reported. Patient received other medications (unspecified) within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Patient previously took Compazine, Percocet, Morphine on an unspecified dates and experienced allergy. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: en6206) via an unspecified route of administration in left arm on an unspecified date in Mar2021 at 15:00 as single dose for COVID-19 immunization. On 01Apr2021 at 22:00 patient experienced chills, fever, every inch of body aching, intestinal agony, rash, headache, nausea, incredible fatigue, site of shot pain- full blown flu/virus, diarrhea. On day 8 patient was still so fatigued and cannot do anything. Diarrhea has stopped but headaches remained, and arm still aches. Patient haven't been this sick in years. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. Patient did not receive any treatment. Outcome of the event diarrhea was resolved on an unspecified date and for other events were not recovered.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: Chills; fever; every inch of body aching; intestinal AGONY; rash; headache; nausea; incredible fatigue/fatigued; site of shot pain; Diarrhea; full blown flu/virus; This is a spontaneous report from a contactable consumer (patient). A 73-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: er8734) via an unspecified route of administration in left arm on 01Apr2021 at 14:30 (at the age of 73-year-old) as single dose for COVID-19 immunization. Medical history of the patient was not reported. Patient received other medications (unspecified) within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Patient previously took Compazine, Percocet, Morphine on an unspecified dates and experienced allergy. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: en6206) via an unspecified route of administration in left arm on an unspecified date in Mar2021 at 15:00 as single dose for COVID-19 immunization. On 01Apr2021 at 22:00 patient experienced chills, fever, every inch of body aching, intestinal agony, rash, headache, nausea, incredible fatigue, site of shot pain- full blown flu/virus, diarrhea. On day 8 patient was still so fatigued and cannot do anything. Diarrhea has stopped but headaches remained, and arm still aches. Patient haven't been this sick in years. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. Patient did not receive any treatment. Outcome of the event diarrhea was resolved on an unspecified date and for other events were not recovered.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Periorbital swelling, Pruritus, Rash
Clinical narrative: After the first shot had swelling around eyes; After the first shot i had swelling around my eyes and they were very itchy.; This is a spontaneous report from a contactable consumer (patient) and Other HCP. This is the first of two reports. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EW0150) via an unspecified route of administration in the arm left on 07Apr2021 at 14:30 (at the age of 23-year-old) at dose 1, single for COVID-19 immunisation. Medical history included syncope, low blood pressure, menstrual issues, environmental allergies and allergic to mushrooms. Concomitant medications included fluoxetine hydrochloride (PROZAC), trazodone (MANUFACTURER UNKNOWN) and birth control, all for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 19:00 after the first shot the patient had swelling around eyes and they were very itchy. The events resulted in emergency room/department visit or urgent care. Patient received treatment with oral steroids for the event swelling around eyes and they were very itchy. The clinical outcome of the event after the first shot had swelling around eyes and they were very itchy was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Eye pruritus, Eye swelling
Clinical narrative: After the first shot had swelling around eyes; After the first shot i had swelling around my eyes and they were very itchy.; This is a spontaneous report from a contactable consumer (patient) and Other HCP. This is the first of two reports. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EW0150) via an unspecified route of administration in the arm left on 07Apr2021 at 14:30 (at the age of 23-year-old) at dose 1, single for COVID-19 immunisation. Medical history included syncope, low blood pressure, menstrual issues, environmental allergies and allergic to mushrooms. Concomitant medications included fluoxetine hydrochloride (PROZAC), trazodone (MANUFACTURER UNKNOWN) and birth control, all for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 19:00 after the first shot the patient had swelling around eyes and they were very itchy. The events resulted in emergency room/department visit or urgent care. Patient received treatment with oral steroids for the event swelling around eyes and they were very itchy. The clinical outcome of the event after the first shot had swelling around eyes and they were very itchy was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Eye pruritus, Eye swelling, Rash
Clinical narrative: After the first shot had swelling around eyes; After the first shot i had swelling around my eyes and they were very itchy.; This is a spontaneous report from a contactable consumer (patient) and Other HCP. This is the first of two reports. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EW0150) via an unspecified route of administration in the arm left on 07Apr2021 at 14:30 (at the age of 23-year-old) at dose 1, single for COVID-19 immunisation. Medical history included syncope, low blood pressure, menstrual issues, environmental allergies and allergic to mushrooms. Concomitant medications included fluoxetine hydrochloride (PROZAC), trazodone (MANUFACTURER UNKNOWN) and birth control, all for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 19:00 after the first shot the patient had swelling around eyes and they were very itchy. The events resulted in emergency room/department visit or urgent care. Patient received treatment with oral steroids for the event swelling around eyes and they were very itchy. The clinical outcome of the event after the first shot had swelling around eyes and they were very itchy was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Periorbital swelling, Pruritus, Rash
Clinical narrative: swelling and itching of my eyes; swelling and itching of my eyes; full body rash abs patches of itching; This is a spontaneous report from a contactable consumer (patient). A 23-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date (Age at Vaccination was 23 years), as dose 2, single for COVID-19 immunization. The patient medical history included syncope, low blood pressure, menstrual issues, Environmental allergies, and allergic to mushrooms. Concomitant medications included Fluoxetine hydrochloride (PROZAC), Trazodone, and birth control. Patient did not receive any other vaccine in four weeks prior COVID vaccination. Patient was not diagnosed with COVID prior vaccination and not tested with COVID post vaccination. The patient previously received first does of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: EW0150) via an unspecified route of administration, administered in Arm Left on 07Apr2021 14:30 (Age at Vaccination was 23 years), as dose 1, single for COVID-19 immunization and on 07Apr2021 19:00, patient experienced swelling around her eyes and they were very itchy and received Oral steroids for swelling and itching. On an unspecified date, the patient experienced swelling and itching of my eyes, and full body rash abs patches of itching. The patient visited Emergency room as a result of events. Therapeutic measures were taken as a result of events which included Oral steroids for swelling and itching. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.